6 Trends, die die Zukunft des digitalen Anzeigenverkaufs für Ad Ops ...
Die Dominanz der Online-Werbeausgaben wird sich dank Digital Out-of-Home (DOOH) ändern, wodurch es möglicht wird, Billboards mit ...
Bayer
Bis 2020 wird das deutsche Pharmaunternehmen <anchor>Bayer</anchor> den gesamten Einkauf digitaler Medien intern abwickeln. Sie werden weiterhin mit externen Agenturen zusammenarbeiten, die ihre Kommunikationsplanung und Offline-Medien verwalten, sowie Kreativagenturen für Kampagnen nutzen.
Pharmaceuticals | Bayer | Bayer Global
Pharmaceuticals \| Bayer \| Bayer Global

[Skip to content](#content)

Health for all, Hunger for none

- [English (EN)](/en/pharma/pharmaceuticals)
- [Deutsch (DE)](/de/pharma/pharmaceuticals)

- [Locations](/en/locations)

- [Contact Us](/en/contact-us)


[![Home](/themes/custom/bayer_cpa/logo.svg)](/en/ "Home")

Bayer
Global


- [This is Bayer](/en/this-is-bayer)






[![girl color party](/sites/default/files/styles/280x160/public/2020-04/girl_color_party.jpg?h=dd503c25&itok=FJPovURt)](/en/this-is-bayer)



Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.







- [Who We Are](/en/this-is-bayer)
- [Profile and Organization](/en/strategy/profile-and-organization)  - [Our Mission & Strategy](/en/strategy/our-mission-strategy)
  - [Our Contributions](/en/our-contributions)
  - [Our Code of Conduct](/en/commitments/code-of-conduct)
  - [Diversity, Equity & Inclusion at Bayer](/en/commitments/diversity-equity-inclusion-at-bayer)    - [Number of Women in Management Positions](/en/inclusion-diversity/women-management-positions)
  - [Team Bayer](/en/team-bayer)    - [Board of Management](/en/board-of-management)      - [Overview and Tasks](/en/board-of-management "Overview and Tasks")
      - [Bill Anderson](/en/board-of-management/bill-anderson)
      - [Wolfgang Nickl](/en/board-of-management/wolfgang-nickl)
      - [Stefan Oelrich](/en/board-of-management/stefan-oelrich)
      - [Heike Prinz](/en/board-of-management/heike-prinz)
      - [Rodrigo Santos](/en/board-of-management/rodrigo-santos)
      - [Julio Triana](/en/board-of-management/julio-triana)
      - [Offices Held at other Companies](/en/board-of-management/offices-held-at-other-companies)
      - [Compensation](/en/board-of-management/compensation)
    - [Supervisory Board](/en/supervisory-board/supervisory-board-of-bayer-ag)      - [Members](/en/supervisory-board/supervisory-board-of-bayer-ag)
      - [Committees](/en/supervisory-board/committees)
      - [Compensation](/en/supervisory-board/compensation-supervisory-board)
    - [Division Leadership](/en/division-leadership)
    - [Working At Bayer](/en/working-at-bayer)
  - [Bayer Worldwide](/en/worldwide/bayer-worldwide)
  - [History](/en/history/history)    - [1863-1881](/en/history/1863-1881)
    - [1881-1914](/en/history/1881-1914)
    - [1914-1925](/en/history/1914-1925)
    - [1925-1945](/en/history/1925-1945)
    - [1945-1951](/en/history/1945-1951)
    - [1951-1974](/en/history/1951-1974)
    - [1974-1988](/en/history/1974-1988)
    - [1988-2001](/en/history/1988-2001)
    - [2001-2010](/en/history/2001-2010)
    - [2010-2022](/en/history/2010-2022)
    - [2023 - Present](/en/history/2023-present)
    - [Biographies](/en/history/biographies)
    - [The Bayer Cross](/en/history/logo-history)
    - [The Corporate Archives](/en/history/the-company-archive)
- [Procurement](/en/procurement)  - [Sustainability in Procurement](/en/procurement/our-approach)    - [Our Approach](/en/procurement/our-approach)
    - [Supplier Code of Conduct](/en/procurement/supplier-code-of-conduct)
    - [Strategic Sustainability Focus Areas](/en/procurement/strategic-sustainability-focus-areas)
    - [Supplier Diversity](/en/procurement/supplier-diversity)
    - [Industry Initiatives](/en/procurement/industry-initiatives)
  - [Supplier Information](/en/procurement/conditions-of-purchase)    - [Conditions of Purchase](/en/procurement/conditions-of-purchase)
    - [Customs & International Trade Guidelines](/en/procurement/customs-and-international-trade-guidelines)
    - [Invoicing](/en/procurement/invoicing)
    - [Downloads & Links](/en/procurement/procurement-downloads-and-links)
  - [Contact Procurement](/en/procurement/contact-procurement)
- [Corporate Compliance](/en/corporate-compliance/corporate-compliance)  - [Information & IT Security](/en/corporate-compliance/information-and-it-security-cyber-crime)
  - [Data Privacy Information For Specific Processing Activities](/en/corporate-compliance/data-privacy-statement-for-specific-processing-activities)
  - [Speak Up Channel](/en/corporate-compliance/speak-up-channel)
- [Calendar](/en/calendar)
- [Contact Us](/en/contact-us)

- [Health](/en/health-at-bayer)






[![Health](/sites/default/files/styles/280x160/public/2022-04/pediatrician.png?h=7f1876e9&itok=GPOYiubg)](https://www.bayer.com/en/health)



As a leader in healthcare, Bayer provides innovative solutions designed to prevent, alleviate and treat diseases.







- [Health at Bayer](/en/health-at-bayer)
- [Pharmaceuticals](/en/pharma/pharmaceuticals)  - [Treatment Areas](/en/pharma/treatment-areas)    - [Cardiology](/en/pharma/cardiology)      - [Thrombosis](/en/pharma/thrombosis)
      - [Heart Attack](/en/pharma/heart-attack)
      - [Diagnosing Heart Disease](/en/pharma/diagnosing-heart-disease)
      - [Heart Failure](/en/pharmaceuticals/living-with-heart-failure)
      - [High Blood Pressure](/en/pharma/high-blood-pressure)
      - [Stroke & Atrial Fibrillation](/en/pharma/stroke-atrial-fibrillation)
    - [Hematology](/en/pharma/hematology)
    - [Oncology](/en/pharma/oncology)      - [Inspired By You](/en/pharma/inspired-by-you)
      - [Gastrointestinal Stromal Tumor](/en/pharma/gastrointestinal-stromal-tumor-gist)
      - [Breast Cancer](/en/pharma/breast-cancer)
      - [Kidney Cancer](/en/pharma/kidney-cancer)
      - [Liver Cancer](/en/pharma/liver-cancer)
      - [Prostate Cancer](/en/pharma/prostate-cancer)
      - [TRK Fusion Cancer](/en/pharma/trk-fusion-cancer)
      - [Thyroid Cancer](/en/pharma/thyroid-cancer)
    - [Chronic Kidney Disease](/en/pharma/chronic-kidney-disease)
    - [Eye Conditions](/en/pharma/eye-conditions)      - [Age-related Macular Degeneration](/en/pharma/age-related-macular-degeneration-amd)
      - [Diabetic Macular Edema](/en/pharma/diabetic-macular-edema-dme)
    - [Healthy Aging](/en/pharma/healthy-aging)
    - [Hormonal & Reproductive Health](/en/pharma/hormonal-reproductive-health)      - [Contraception](/en/pharma/contraception)
      - [Endometriosis](/en/pharma/endometriosis)
      - [Heavy Menstrual Bleeding](/en/pharma/heavy-menstrual-bleeding)
      - [Menopause](/en/pharma/menopause)
      - [Acne Therapy](/en/pharma/acne-therapy)
  - [Innovation & Technologies](/en/pharma/innovation-research)    - [Trends](/en/pharma/trends)      - [AAV Therapeutics](/en/pharma/aav-therapeutics-fighting-genetic-diseases-their-source)
      - [Stem cells - The new age of medical research](/en/pharma/stem-cells-new-age-medical-research)
      - [Pharmacogenetics](/en/pharma/pharmacogenetics)
      - [Biomarkers](/en/pharma/biomarkers)
      - [Precision Medicine](/en/pharma/precision-medicine)
      - [United against Parkinson’s Disease](/en/pharma/united-against-parkinsons-disease)
      - [Unlocking the Undruggable Space](/en/pharma/unlocking-the-undruggable-space)
    - [Pipeline](/en/pharma/development-pipeline)      - [Clinical Trials](/en/pharma/clinical-trials)        - [Worldwide Standards](/en/pharma/worldwide-standards)
      - [Ethics in Clinical Trials](/en/pharma/ethics-clinical-trials)
      - [FAQ](/en/pharma/faq)
      - [Access to investigational medicines](/en/pharma/access-investigational-medicines)
    - [Technology](/en/pharma/technologies)      - [Artificial Intelligence](/en/pharma/artificial-intelligence)
      - [Chemoproteomics](/en/pharma/chemoproteomics)
      - [PROTAC's](/en/pharma/protacs)
      - [RNA-targeting SMOLs](/en/pharma/rna-targeting-small-molecules)
      - [Diagnostic Imaging](/en/pharma/diagnostic-imaging)
    - [Partnering](/en/pharma/partnering)      - [Chemical Probes For Open Access](/en/pharma/chemical-probes-open-access)
    - [Oncology](/en/pharma/challenging-cancer-with-precision-medicine)      - [Covalent binding – Vividion](/en/pharma/covalent-binding-vividion)
      - [Immuno-oncology](/en/pharma/immuno-oncology)
      - [Targeted Alpha Therapy](/en/pharma/targeted-alpha-therapy)
      - [Tumor Intrinsic Pathways](/en/pharma/tumor-intrinsic-pathways)
    - [Innovation powered by people](/en/pharma/innovation-powered-by-people)
  - [Cell and Gene Therapy](/en/pharma/cell-and-gene-therapy)    - [Gene Therapy](/en/pharma/gene-therapy)
    - [Cell Therapy](/en/pharma/cell-therapy)
    - [Gene Editing](/en/pharma/gene-editing)
  - [Sustainability](/en/pharma/initiatives)    - [Patient Access Charter](/en/pharma/bayer-pharmaceutical-division-patient-access-charter)
    - [Leadership Perspective](/en/pharma/leadership-perspective)
    - [Strengthening Healthcare Access](/en/pharma/strengthening-healthcare-access)
    - [Empowering Women, Globally](/en/pharma/empowering-women-globally)      - [Boosting Family Planning Usage through Digital Channels](/en/pharma/advancing-digital-reproductive-health)
      - [Capacity building: Addressing Root Causes through Partnerships](/en/pharma/capacity-building)
      - [Impact at Scale: The Challenge Initiative](/en/pharma/partnership-with-the-challenge-initiative)
      - [Promoting Awareness: World Contraception Day (WCD) & the Your Life Campaign](/en/pharma/world-contraception-day-and-your-life-campaign)
      - [Providing Accessible and Affordable Contraceptives](/en/pharma/providing-accessible-and-affordable-contraceptives)
      - [Enabling Family Planning in Humanitarian Settings](/en/pharma/family-planning-in-humanitarian-settings)
    - [Fighting Neglected Tropical Diseases](/en/pharma/fighting-neglected-tropical-diseases)      - [Chagas Disease](/en/pharma/chagas-disease)
    - [Moving Non-Communicable Diseases Care Forward](/en/pharma/non-communicable-disease-care)
    - [Ensuring a Sustainable Product Supply](/en/pharma/sustainability)
    - [Delivering Better Cancer Care](/en/pharma/delivering-better-cancer-care)
  - [Transparency](/en/pharma/patient-organization)    - [Patient Organization](/en/pharma/patient-organization)
    - [Patient Engagement](/en/pharma/patient-engagement)
  - [News & Stories](/en/pharma/news-stories)
- [Personal Health](/en/personal-health/better-health-for-all)  - [Solutions](/en/personal-health/aiding-digestion)    - [Aiding Digestion](/en/personal-health/aiding-digestion)
    - [Caring for Skin](/en/personal-health/caring-for-skin)
    - [Fighting Pain](/en/personal-health/fighting-pain)
    - [Protecting Heart Health](/en/personal-health/protecting-heart-health)
    - [Relieving Allergies](/en/personal-health/relieving-allergies)
    - [Supporting Nutrition](/en/personal-health/supporting-nutrition)
    - [Treating Cold and Flu Symptoms](/en/personal-health/treating-cold-and-flu-symptoms)
  - [Products](/en/personal-health/consumer-health-products)
  - [Innovation](/en/personal-health/innovating-better-everyday-health-for-all-of-us)    - [Partnerships](/en/personal-health/partnering-to-achieve-health-for-all)
    - [Trust and Credibility](/en/personal-health/a-century-of-science)
    - [Science-Led Self-Care](/en/personal-health/science-led-self-care)
  - [Our Commitments](/en/personal-health/consumer-health-commitments)    - [Creative and Responsible Marketing](/en/personal-health/creative-and-responsible-marketing)
    - [Empowering Personal Health Sustainably](/en/personal-health/empowering-personal-health-sustainably)
    - [The Nutrient Gap Initiative](/en/personal-health/the-nutrient-gap-initiative)
  - [News & Stories](/en/personal-health/news-stories-personal-health)
- [Report a Side Effect](/en/health/report-side-effect)
- [Medical Counterfeits](/en/health/beware-of-counterfeits)  - [Recognizing Fakes](/en/health/recognizing-fakes)    - [EU Verification Logo against Counterfeit Drugs](/en/health/eu-verification-logo-for-reputable-online-pharmacies)
    - [Background Information](/en/health/background-information-on-counterfeit-drugs)
    - [Recognizing Fraudulent Brands](/en/health/recognizing-fraudulent-brands)
    - [New Safety Features for Prescription Medicine in Europe](/en/health/new-safety-features-for-prescription-medicine-in-europe)
    - [Commitment to Fighting Counterfeit Drugs](/en/health/bayers-commitment-to-fighting-counterfeit-drugs)
    - [Links](/en/health/taking-action-against-counterfeit-drugs)

- [Agriculture](/en/agriculture-overview)






[![Agriculture](/sites/default/files/styles/280x160/public/2022-04/farmer.png?h=7f1876e9&itok=-D3LkwsQ)](https://www.bayer.com/en/agriculture)



Bayer provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy.







- [Overview](/en/agriculture-overview)
- [Farmer Voice](/en/agriculture/farmer-voice)
- [Regenerative Agriculture](/en/agriculture/regenerativeag)  - [Solutions](/en/agriculture/tailored-solutions)    - [Agriculture Biologicals](/en/agriculture/agriculture-biologicals)
    - [Crop Protection](/en/agriculture/crop-protection)      - [Weed Management](/en/agriculture/weed-management)
      - [Disease Management](/en/agriculture/disease-management)
      - [Insect Management](/en/agriculture/insect-management)
    - [Seeds & Traits](/en/agriculture/seeds-traits)      - [Biotechnology](/en/agriculture/gmo-biotechnology)
      - [Genome Editing](/en/agriculture/genome-editing)
      - [Plant Breeding](/en/agriculture/plant-breeding)
    - [Digital Farming](/en/agriculture/digital-farming-systems)      - [Smart Solutions](/en/agriculture/digital-farming)
      - [Bayer and Microsoft Partnership](/en/agriculture/bayer-and-microsoft-partnership)
    - [Fruits & Vegetables](/en/agriculture/fruits-vegetables)
  - [Sustainability Commitments](/en/agriculture/sustainability-commitments)    - [Water Commitment](/en/agriculture/agriculture-water-commitment)
    - [Empowering Smallholder Farmers](/en/agriculture/empowering-smallholder-farmers)      - [Impact on Smallholder Livelihoods](/en/agriculture/impact-on-smallholder-livelihoods)
      - [Smallholder-Centric Solutions](/en/agriculture/smallholder-centric-solutions)
      - [Collaboration in Value-Chain Partnerships](/en/agriculture/collaboration-in-value-chain-partnerships)
    - [Reducing Crop Protection’s Environmental Impact](/en/agriculture/reducing-agricultures-impact-environment)      - [Environmental Impact Reduction Reporting Results](/en/crop-science/results-and-progress-reviewed-by-external-experts)
  - [Climate Change](/en/agriculture/climate-change)    - [CoverCress](/en/agriculture/cover-cress)
    - [Our Carbon Zero Commitment](/en/agriculture/carbon-zero)
    - [U.S. Carbon Program](/en/agriculture/carbon-program-united-states)
    - [European Carbon Program](/en/agriculture/our-goal-to-decarbonize-agriculture)
    - [PRO Carbono Brasil](/en/node/28291)
    - [GHG Progress Reporting](/en/agriculture/greehouse-gas-results-and-progress "Bayer aims to verify that it uses the CFT calculator in a reasonable approach and that the baselining and performance tracking methodology is adequate")
  - [Biodiversity](/en/agriculture/biodiversity)    - [Restoring Biodiversity](/en/agriculture/restoring-biodiversity)
    - [Natural Resource Conservation](/en/agriculture/natural-resource-conservation)      - [Water](/en/agriculture/water-conservation)
      - [Soil Health](/en/agriculture/soil-health)
      - [Land Preservation](/en/agriculture/land-preservation)
  - [The Crop Science Sustainability Progress Report](/en/sustainability-progress-report)    - [Reporting Matters](/en/reporting-matters)
- [Advances in Agriculture](/en/agriculture/advances-agriculture)  - [Farms of the Future](/en/agriculture/farms-of-the-future)
  - [Innovation Showcase](/en/agriculture/innovation-showcase)
  - [Innovation Pipeline](/en/agriculture/pipeline)
  - [Collaborations & Open Innovation](/en/agriculture/collaborations)    - [Global LifeHub Network](/en/agriculture/global-lifehub-network)
- [Food Security](/en/agriculture/food-security)  - [Beyond Growing More](/en/agriculture/beyond-growing-more)
  - [Resilient Food Systems](/en/agriculture/resilient-food-systems)
  - [Nutrition](/en/agriculture/nourishing-the-world)
  - [Food Safety](/en/agriculture/food-safety)
  - [Food Loss & Waste](/en/agriculture/food-loss-waste)
  - [Food Chain Partnership](/en/agriculture/food-chain-partnership)
- [Products](/en/agriculture/products)  - [Suppliers](/en/agriculture/suppliers-crop-science)
  - [Counterfeits in Agriculture](/en/agriculture/counterfeits-in-agriculture)    - [Recognize & Avoid Counterfeits](/en/agriculture/recognize-and-avoid-counterfeits)
    - [Bayer´s Role In Combating Counterfeits](/en/agriculture/bayer-s-role-in-combating-counterfeits)
    - [Bayer Safety Seal & Bayer Seal Scan App](/en/agriculture/bayer-safety-seal)
  - [Product Responsibility](/en/agriculture/taking-product-responsibility)
  - [Product Stewardship](/en/agriculture/product-stewardship)    - [Safe Use Ambassador](/en/agriculture/safe-use-ambassadors)
  - [Product Supply](/en/agriculture/creating-sustainable-product-supply)
- [Transparency](/en/agriculture/transparency-crop-science)  - [Crop Protection](/en/agriculture/transparency-in-crop-protection)
  - [OpenLabs](/en/agriculture/open-labs)
  - [GMO Crops](/en/agriculture/transparency-gmo-crops)
  - [Plant Breeding](/en/agriculture/transparency/plant-breeding)
- [News & Stories](/en/agriculture/news-stories)  - [Events](/en/agriculture/events)    - [Bayer Innovation](/en/agriculture/bayer-innovation)
    - [Youth Ag Summit](/en/agriculture/youth-ag-summit)
  - [Podcast](/en/agriculture/podcast)
- [Contact Us](/en/agriculture/contact-us-cropscience)

- [Products](/en/products/products-overview)






[![Products](/sites/default/files/styles/280x160/public/2020-04/pharmacy_shelf.jpg?h=dd503c25&itok=dPWJY4p5)](/en/products/products-overview)



Innovative products for the health of humans and plants.







- [Overview](/en/products/products-overview)
- [Product Areas](/en/products/product-portfolio-of-bayer)
- [Information for Patients](/en/products/risks-benefits-drugs-patient-information)
- [Beware of Counterfeits](/en/products/beware-of-counterfeits)
- [Report a Side-Effect](/en/products/report-a-side-effect)
- [Products from A to Z](/en/products/products-from-A-to-Z)

- [Innovation](/en/innovation/breakthrough-innovation-a-new-era-of-discovery)






[![Innovation](/sites/default/files/styles/280x160/public/2020-04/Original%20innovation.jpg?h=dd503c25&itok=d499PL13)](/en/innovation/breakthrough-innovation-a-new-era-of-discovery)



For more than 160 years, Bayer has been driving innovation to improve people's lives.







- [Breakthrough Innovation](/en/innovation/breakthrough-innovation-a-new-era-of-discovery)  - [Conserving Natural Resources in Agriculture](/en/news-stories/short-corn-is-smart-corn)
  - [Rewriting the Future of Healthcare](/en/innovation/rewriting-the-future-of-healthcare)
  - [Unleashing the Potential of AI](/en/innovation/unleashing-the-potential-of-ai)
- [Leaps by Bayer](/en/innovation/leaps)
- [Science, Research & Innovation](/en/innovation/science-research-and-innovation)  - [Our Innovation Approach](/en/innovation/our-innovation-approach)
  - [How We Develop Our Talents](/en/innovation/how-we-develop-our-talents)
  - [Open Innovation and Engagement](/en/innovation/open-innovation-and-engagement)
  - [Our Values for Science and Research](/en/innovation/our-values-for-science-and-research)
- [Spotlight](/en/innovation/innovation-spotlight)

- [Sustainability](/en/sustainability/at-a-glance)






[![sustainability](/sites/default/files/styles/280x160/public/2020-04/hands-check-wheatears-at-the-field_0.jpg?h=dd503c25&itok=Z24n9VKV)](/en/sustainability/at-a-glance)



Read more about our economic, ecological and social challenges and opportunities.







- [At a Glance](/en/sustainability/at-a-glance)  - [Latest Updates](/en/sustainability/latest-updates-on-sustainability)
  - [ESG Topics](/en/sustainability/esg-topics)
  - [The Nutrient Gap Initiative](/en/the-nutrient-gap-initiative)
- [Strategy & Targets](/en/sustainability/sustainability-strategy)  - [Strategy](/en/sustainability/sustainability-strategy)
  - [Targets](/en/sustainability/targets)
  - [Impact](/en/sustainability/people-thrive "This is how we help people thrive")
- [Reports](/en/sustainability/sustainability-reports)  - [Sustainability Report](/en/sustainability/sustainability-reports)
  - [Additional Reports](/en/sustainability/additional-reports)
- [ESG Ratings and Rankings](/en/sustainability/esgratings)
- [Climate, Environment and Safety](/en/sustainability/climate-commitment-net-zero-2050)  - [Climate Protection](/en/sustainability/climate-commitment-net-zero-2050)
  - [Water Stewardship](/en/sustainability/water-stewardship)
  - [Environmental Protection](/en/sustainability/environmental-protection)
  - [Health and Safety](/en/sustainability/health-and-safety)
- [People](/en/sustainability/working-at-bayer-excellent-perspectives)  - [Employees](/en/sustainability/working-at-bayer-excellent-perspectives)
  - [Human Rights](/en/sustainability/human-rights)    - [Modern Slavery Statement](/en/sustainability/bayer-modern-slavery-statement)
- [Management & Governance](/en/sustainability/sustainability-management)  - [Bayer Sustainability Council](/en/sustainability/bayer-sustainability-council)
  - [Bayer Bioethics Council](/en/sustainability/the-bayer-bioethics-council)
  - [Stakeholder Dialogue](/en/sustainability/stakeholder-dialogue)
  - [UN Global Compact](/en/sustainability/global-compact)
  - [Group Regulations](/en/sustainability/sustainable-policy)    - [Bayer Human Rights Policy](/en/sustainability/bayer-human-rights-policy)
    - [Responsible Marketing & Sales](/en/sustainability/responsible-marketing-sales-regulation)
    - [Corporate Compliance](/en/sustainability/corporate-compliance-en)
  - [Group Positions](/en/sustainability/position-biodiversity)    - [BASE](/en/sustainability/base)
    - [Bioethical Principles](/en/sustainability/bioethical-principles)
    - [Protection of Biodiversity](/en/sustainability/position-biodiversity)
    - [Position on Global Product Strategy](/en/sustainability/position-on-global-product-strategy)
    - [Position on Responsible Care](/en/sustainability/position-on-responsible-care)
    - [Position on Deforestation and Forest Degradation](/en/sustainability/position-on-deforestation-and-forest-degradation)
    - [Position on Insect Decline](/en/sustainability/our-views-on-insect-decline "Position on Insect Decline")
    - [Raising the Bar on Crop Protection Safety Standards](/en/sustainability/raising-the-bar-on-crop-protection-safety-standards "Raising the Bar on Crop Protection Safety Standards")
    - [UN Sustainable Development Goals](/en/bayers-position-towards-un-sustainable-development-goals)
    - [Position on Sustainable Beef Production](/en/sustainability/position-sustainable-beef)
  - [Supplier Management](/en/sustainability/supplier-management)
- [Transparency](/en/sustainability/transparency)  - [Commitment & Overview](/en/sustainability/transparency)
  - [Political Engagement](/en/sustainability/political-principles-and-positions)
  - [Code of Conduct for Responsible Lobbying](/en/sustainability/code-of-conduct-for-responsible-lobbying)
  - [Transfers of Values to Healthcare Professionals](/en/sustainability/payments-to-healthcare-professionals)    - [Commitment](/en/sustainability/payments-to-healthcare-professionals)
    - [Collaboration with Healthcare Professionals](/en/sustainability/collaboration-with-healthcare-professionals)
    - [Our Disclosure Obligations](/en/sustainability/our-disclosure-obligations)
  - [Science Collaborations](/en/sustainability/transparency-in-science-collaborations)
  - [Product Stewardship](/en/sustainability/product-stewardship)    - [Overview](/en/sustainability/product-stewardship)
    - [Pharmaceuticals & Medical Devices](/en/sustainability/product-stewardship-healthcare-business)
    - [Crop Protection Products & Seeds](/en/sustainability/product-stewardship-agriculture-farming)
  - [ESG Investor Engagement and Webinars](/en/sustainability/esg-investor-update-webinar-june-2024)    - [ESG Investor Webinar June 2024](/en/sustainability/esg-investor-update-webinar-june-2024)
    - [ESG Investor Update Webinar March 2023](/en/sustainability/esg-investor-update-webinar)
    - [Crop Science ESG Investor Webinar October 2023](/en/sustainability/crop-science-esg-investor-webinar-oct-2023)
    - [UN Global Compact Adherence Webinar June 2022](/en/sustainability/initiatives)
    - [ESG Investor Engagement Activities](/en/sustainability/esg-investor-engagement-activities)
  - [Transparency Reporting](/en/sustainability/transparency-reporting)
- [Societal Engagement](/en/corporate-giving-social-innovation)  - [Corporate Giving & Social Innovation](/en/corporate-giving-social-innovation)    - [Science Education](/en/societal-engagement/science-education)
  - [Culture of Remembrance](/en/societal-engagement/culture-of-remembrance)
  - [Bayer Clubs](/en/societal-engagement/clubs-sports-culture-hobby-bayer)
  - [Culture](/en/societal-engagement/culture-arts-promotion-program)
  - [Sports](/en/societal-engagement/bayer-sports-sponsor-overview)    - [Bayer and Sports](/en/societal-engagement/bayer-sports-sponsor-overview)
    - [Successful Bayer Athletes](/en/societal-engagement/medals-achievements-bayer-athletes)
    - [Parasport](/en/societal-engagement/disabled-sports-sponsorship-paralympics)
    - [Promotion of New Talent](/en/societal-engagement/sports-promotion-talents-bayer)
    - [Bayer 04 Leverkusen](/en/societal-engagement/bayer-04-leverkusen-soccer)

- [Media](/en/media-overview)






[![finger-tipping-at-tablet](/sites/default/files/styles/280x160/public/2024-01/finger-tipping-at-tablet.jpg?h=8c18b745&itok=iNq4ws1Z)](https://www.bayer.com/en/media)



Besides news this area provides further useful information like interesting stories, visual assets, an event calendar and media contacts.







- [Overview](/en/media-overview)
- [News](https://www.bayer.com/media/en-us/)
- [Stories](/en/news-stories)
- [Speeches](https://www.bayer.com/media/en-us/speeches/)
- [Visual Assets](/en/media/visual-assets)
- [Social Media](/en/media/social-media-channels)
- [Events](/en/media/events)
- [Media Contacts](/en/media/media-contacts)

- [Investors](/en/investors-overview)







![Multiethnic_employees_looking_at_laptop](/sites/default/files/styles/280x160/public/2020-11/Multiethnic_employees_looking_at_laptop_426x240.jpg?h=17ea040c&itok=STrKynjd)




Creating transparency, fostering dialogue, and delivering value to our stakeholders.







- [Overview](/en/investors-overview)
- [Our Mission & Strategy](/en/strategy/our-mission-strategy)
- [Investor News](/en/investors/investor-news)  - [Ad Hoc](/en/investors/ad-hoc)
- [Events & Presentations](/en/investors/events)  - [Events Archive](/en/investors/events-archive)
  - [Annual Stockholders' Meeting](/en/investors/annual-stockholders-meeting)    - [Notice of the Meeting & Agenda](/en/investors/notice-of-the-meeting-agenda-asm2024)
    - [Stockholders’ Portal](https://www.stockholders-portal.bayer.com/)
    - [Countermotions and Proposals for Election](/en/investors/countermotions-election-proposals-asm2024)
    - [Stockholder Statements](/en/investors/stockholder-statements-asm2024)
    - [Right to speak](/en/investors/speak-asm2024)
    - [Right of information](/en/investors/questions-asm2024)
    - [Right to object](/en/investors/objections-asm2024)
    - [How to Vote](/en/investors/how-to-vote-asm2024)
    - [FAQs](/en/investors/faq-asm2024)
    - [Voting Results](/en/investors/voting-results-asm2024)
    - [ASM-Services & -Downloads](/en/investors/services-downloads-asm2024)
    - [ASM Archive](/en/investors/agm-archive)
- [Financial Reports](/en/investors/financial-reports)  - [Quarterly Reports](/en/investors/quarterly-reports)
  - [Annual Reports](/en/investors/integrated-annual-reports)
  - [Bayer AG Financial Statements](/en/investors/bayer-ag-financial-statements)
  - [Compensation Reports and Compensation Systems](/en/investors/compensation-reports)
- [Shareholder Information](/en/investors/shareholder-information)  - [Stock Chart](/en/investors/stock-chart)
  - [Analyst Consensus](/en/investors/analyst-consensus)
  - [Dividends](/en/investors/dividends)
  - [Return Calculator](/en/investors/return-calculator)
  - [Voting Rights Announcements](/en/investors/voting-rights-announcements)    - [Overview](/en/investors/voting-rights-announcements)
    - [Archive](/en/investors/archive-voting-rights-announcements)
  - [ADR Program](/en/investors/adr-program)
- [Debt](/en/investors/debt)
- [Sustainable Investing](/en/sustainability/at-a-glance)
- [Corporate Governance](/en/investors/corporate-governance)  - [Duties and Activities of the Board of Management](/en/investors/duties-and-activities-of-the-board-of-management)
  - [Supervisory Board](/en/investors/supervisory-board)
  - [Disclosure of Managers' Transactions](/en/investors/disclosure-of-managers-transactions)
  - [Approach to Tax](/en/investors/approach-to-tax)
  - [Control](/en/investors/control)
  - [Corporate Compliance](/en/investors/corporate-compliance-program)
  - [Links & Downloads](/en/investors/links-and-downloads)
- [Investor Downloads](/en/investors/document-download-tool)
- [Contact Us](/en/investors/ir-team)

- [Career](/en/career)







![Career](/sites/default/files/styles/280x160/public/2021-07/EB-EXT_dropdown_0.jpg?h=8c18b745&itok=Cz88GH2d)




Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.







- [Career](/en/career)
- [Our culture](/en/career/our-culture)
- [Your benefits](/en/career/your-benefits)
- [Your career](/en/career/your-career)
- [Our people](/en/career/our-people)  - [Follow your dreams](/en/career/why-its-worth-to-follow-your-dreams)
  - [our people i belong here](/en/career/our-people-i-belong-here)
- [How to join us](/en/career/how-to-join-us)  - [IT Career](/en/career/it-career)
- [Contact us](/en/career/contact-us)

Enter Search term

## Breadcrumb

1. [Home](https://www.bayer.com/en/)
2. [Health](https://www.bayer.com/en/health-at-bayer)
3. Pharmaceuticals

Pharmaceuticals

# Fighting Diseases

![A swimmer is swimming underwater in a pool.](/sites/default/files/styles/1500x250/public/2021-10/hero-image_1_1.jpg?h=8200f6e4&itok=sFUDRyMI)

- [Health at Bayer](/en/health-at-bayer)
- [Pharmaceuticals](/en/pharma/pharmaceuticals)  - [Treatment Areas](/en/pharma/treatment-areas)    - [Cardiology](/en/pharma/cardiology)      - [Thrombosis](/en/pharma/thrombosis)
      - [Heart Attack](/en/pharma/heart-attack)
      - [Diagnosing Heart Disease](/en/pharma/diagnosing-heart-disease)
      - [Heart Failure](/en/pharmaceuticals/living-with-heart-failure)
      - [High Blood Pressure](/en/pharma/high-blood-pressure)
      - [Stroke & Atrial Fibrillation](/en/pharma/stroke-atrial-fibrillation)
    - [Hematology](/en/pharma/hematology)
    - [Oncology](/en/pharma/oncology)      - [Inspired By You](/en/pharma/inspired-by-you)
      - [Gastrointestinal Stromal Tumor](/en/pharma/gastrointestinal-stromal-tumor-gist)
      - [Breast Cancer](/en/pharma/breast-cancer)
      - [Kidney Cancer](/en/pharma/kidney-cancer)
      - [Liver Cancer](/en/pharma/liver-cancer)
      - [Prostate Cancer](/en/pharma/prostate-cancer)
      - [TRK Fusion Cancer](/en/pharma/trk-fusion-cancer)
      - [Thyroid Cancer](/en/pharma/thyroid-cancer)
    - [Chronic Kidney Disease](/en/pharma/chronic-kidney-disease)
    - [Eye Conditions](/en/pharma/eye-conditions)      - [Age-related Macular Degeneration](/en/pharma/age-related-macular-degeneration-amd)
      - [Diabetic Macular Edema](/en/pharma/diabetic-macular-edema-dme)
    - [Healthy Aging](/en/pharma/healthy-aging)
    - [Hormonal & Reproductive Health](/en/pharma/hormonal-reproductive-health)      - [Contraception](/en/pharma/contraception)
      - [Endometriosis](/en/pharma/endometriosis)
      - [Heavy Menstrual Bleeding](/en/pharma/heavy-menstrual-bleeding)
      - [Menopause](/en/pharma/menopause)
      - [Acne Therapy](/en/pharma/acne-therapy)
  - [Innovation & Technologies](/en/pharma/innovation-research)    - [Trends](/en/pharma/trends)      - [AAV Therapeutics](/en/pharma/aav-therapeutics-fighting-genetic-diseases-their-source)
      - [Stem cells - The new age of medical research](/en/pharma/stem-cells-new-age-medical-research)
      - [Pharmacogenetics](/en/pharma/pharmacogenetics)
      - [Biomarkers](/en/pharma/biomarkers)
      - [Precision Medicine](/en/pharma/precision-medicine)
      - [United against Parkinson’s Disease](/en/pharma/united-against-parkinsons-disease)
      - [Unlocking the Undruggable Space](/en/pharma/unlocking-the-undruggable-space)
    - [Pipeline](/en/pharma/development-pipeline)      - [Clinical Trials](/en/pharma/clinical-trials)        - [Worldwide Standards](/en/pharma/worldwide-standards)
      - [Ethics in Clinical Trials](/en/pharma/ethics-clinical-trials)
      - [FAQ](/en/pharma/faq)
      - [Access to investigational medicines](/en/pharma/access-investigational-medicines)
    - [Technology](/en/pharma/technologies)      - [Artificial Intelligence](/en/pharma/artificial-intelligence)
      - [Chemoproteomics](/en/pharma/chemoproteomics)
      - [PROTAC's](/en/pharma/protacs)
      - [RNA-targeting SMOLs](/en/pharma/rna-targeting-small-molecules)
      - [Diagnostic Imaging](/en/pharma/diagnostic-imaging)
    - [Partnering](/en/pharma/partnering)      - [Chemical Probes For Open Access](/en/pharma/chemical-probes-open-access)
    - [Oncology](/en/pharma/challenging-cancer-with-precision-medicine)      - [Covalent binding – Vividion](/en/pharma/covalent-binding-vividion)
      - [Immuno-oncology](/en/pharma/immuno-oncology)
      - [Targeted Alpha Therapy](/en/pharma/targeted-alpha-therapy)
      - [Tumor Intrinsic Pathways](/en/pharma/tumor-intrinsic-pathways)
    - [Innovation powered by people](/en/pharma/innovation-powered-by-people)
  - [Cell and Gene Therapy](/en/pharma/cell-and-gene-therapy)    - [Gene Therapy](/en/pharma/gene-therapy)
    - [Cell Therapy](/en/pharma/cell-therapy)
    - [Gene Editing](/en/pharma/gene-editing)
  - [Sustainability](/en/pharma/initiatives)    - [Patient Access Charter](/en/pharma/bayer-pharmaceutical-division-patient-access-charter)
    - [Leadership Perspective](/en/pharma/leadership-perspective)
    - [Strengthening Healthcare Access](/en/pharma/strengthening-healthcare-access)
    - [Empowering Women, Globally](/en/pharma/empowering-women-globally)      - [Boosting Family Planning Usage through Digital Channels](/en/pharma/advancing-digital-reproductive-health)
      - [Capacity building: Addressing Root Causes through Partnerships](/en/pharma/capacity-building)
      - [Impact at Scale: The Challenge Initiative](/en/pharma/partnership-with-the-challenge-initiative)
      - [Promoting Awareness: World Contraception Day (WCD) & the Your Life Campaign](/en/pharma/world-contraception-day-and-your-life-campaign)
      - [Providing Accessible and Affordable Contraceptives](/en/pharma/providing-accessible-and-affordable-contraceptives)
      - [Enabling Family Planning in Humanitarian Settings](/en/pharma/family-planning-in-humanitarian-settings)
    - [Fighting Neglected Tropical Diseases](/en/pharma/fighting-neglected-tropical-diseases)      - [Chagas Disease](/en/pharma/chagas-disease)
    - [Moving Non-Communicable Diseases Care Forward](/en/pharma/non-communicable-disease-care)
    - [Ensuring a Sustainable Product Supply](/en/pharma/sustainability)
    - [Delivering Better Cancer Care](/en/pharma/delivering-better-cancer-care)
  - [Transparency](/en/pharma/patient-organization)    - [Patient Organization](/en/pharma/patient-organization)
    - [Patient Engagement](/en/pharma/patient-engagement)
  - [News & Stories](/en/pharma/news-stories)
- [Personal Health](/en/personal-health/better-health-for-all)  - [Solutions](/en/personal-health/aiding-digestion)    - [Aiding Digestion](/en/personal-health/aiding-digestion)
    - [Caring for Skin](/en/personal-health/caring-for-skin)
    - [Fighting Pain](/en/personal-health/fighting-pain)
    - [Protecting Heart Health](/en/personal-health/protecting-heart-health)
    - [Relieving Allergies](/en/personal-health/relieving-allergies)
    - [Supporting Nutrition](/en/personal-health/supporting-nutrition)
    - [Treating Cold and Flu Symptoms](/en/personal-health/treating-cold-and-flu-symptoms)
  - [Products](/en/personal-health/consumer-health-products)
  - [Innovation](/en/personal-health/innovating-better-everyday-health-for-all-of-us)    - [Partnerships](/en/personal-health/partnering-to-achieve-health-for-all)
    - [Trust and Credibility](/en/personal-health/a-century-of-science)
    - [Science-Led Self-Care](/en/personal-health/science-led-self-care)
  - [Our Commitments](/en/personal-health/consumer-health-commitments)    - [Creative and Responsible Marketing](/en/personal-health/creative-and-responsible-marketing)
    - [Empowering Personal Health Sustainably](/en/personal-health/empowering-personal-health-sustainably)
    - [The Nutrient Gap Initiative](/en/personal-health/the-nutrient-gap-initiative)
  - [News & Stories](/en/personal-health/news-stories-personal-health)
- [Report a Side Effect](/en/health/report-side-effect)
- [Medical Counterfeits](/en/health/beware-of-counterfeits)  - [Recognizing Fakes](/en/health/recognizing-fakes)    - [EU Verification Logo against Counterfeit Drugs](/en/health/eu-verification-logo-for-reputable-online-pharmacies)
    - [Background Information](/en/health/background-information-on-counterfeit-drugs)
    - [Recognizing Fraudulent Brands](/en/health/recognizing-fraudulent-brands)
    - [New Safety Features for Prescription Medicine in Europe](/en/health/new-safety-features-for-prescription-medicine-in-europe)
    - [Commitment to Fighting Counterfeit Drugs](/en/health/bayers-commitment-to-fighting-counterfeit-drugs)
    - [Links](/en/health/taking-action-against-counterfeit-drugs)

[![A line icon of a woman's head.](/sites/default/files/styles/16_9_small/public/2021-09/ph-icon.png?h=dcbde0b6&itok=YbYJmXsj)\
\
**I am a Patient**\
\
LEARN MORE](/en/pharma/empowering-solutions-human-health)

[![A line icon of a doctor wearing a helmet.](/sites/default/files/styles/16_9_small/public/2021-09/ph-icon2.png?h=dcbde0b6&itok=zSPyUpEq)\
\
**I am a Professional**\
\
LEARN MORE](/en/pharma/30-years-now)

[![A line icon of two hands with a star in the middle.](/sites/default/files/styles/16_9_small/public/2021-09/ph-icon3.png?h=dcbde0b6&itok=l0Yjxiuz)\
\
**I am a potential Partner**\
\
LEARN MORE](/en/pharma/partnering)

![Doctor with hand on shoulder of cancer patient](/sites/default/files/styles/16_9_aspect_ratio/public/2022-05/screen-shot-2022-05-17-2.32.43-pm.png?h=6f7f1d35&itok=TLkZIQhp)

We Care

01:30

00:00

Latest News

September 01, 2024


Not intended for U.S. and UK - Media Late-Breaking data from pivotal Phase III FINEARTS-HF study presented at ESC Congress 2024


Finerenone showed statistically significant improvement in cardiovascular outcomes in adults with common form of heart failure with high unmet medical need


[READ MORE](https://www.bayer.com/media/en-us/finerenone-showed-statistically-significant-improvement-in-cardiovascular-outcomes-in-adults-with-common-form-of-heart-failure-with-high-unmet-medical-need/)

August 29, 2024


Not intended for UK Media


Bayer starts Phase III trial in non-small cell lung cancer (NSCLC)


[READ MORE](https://www.bayer.com/media/en-us/bayer-starts-phase-iii-trial-in-non-small-cell-lung-cancer-nsclc/)

August 22, 2024


Not intended for UK Media


The Journal of American Medical Association (JAMA) publishes Elinzanetant Phase III data


[READ MORE](https://www.bayer.com/media/en-us/the-journal-of-american-medical-association-jama-publishes-elinzanetant-phase-iii-data/)

August 06, 2024


Second quarter of 2024


Bayer: Modest performance in challenging agricultural market environment – Group outlook confirmed


[READ MORE](https://www.bayer.com/media/en-us/bayer-modest-performance-in-challenging-agricultural-market-environment--group-outlook-confirmed/)

August 05, 2024


Not intended for U.S. and UK Media


Finerenone meets primary endpoint in Phase III FINEARTS-HF cardiovascular outcomes study in patients with heart failure with mildly reduced or preserved ejection fraction


[READ MORE](https://www.bayer.com/media/en-us/finerenone-meets-primary-endpoint-in-phase-iii-finearts-hf-cardiovascular-outcomes-study-in-patients-with-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)

August 01, 2024


Not intended for UK Media


Bayer submits New Drug Application to U.S. FDA for elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause


[READ MORE](https://www.bayer.com/media/en-us/bayer-submits-new-drug-application-to-us-fda-for-elinzanetant-for-the-treatment-of-moderate-to-severe-vasomotor-symptoms-associated-with-menopause/)

July 17, 2024


Not intended for U.S. and UK Media


Darolutamide meets primary endpoint in Phase III ARANOTE trial in men with metastatic hormone-sensitive prostate cancer


[READ MORE](https://www.bayer.com/media/en-us/darolutamide-meets-primary-endpoint-in-phase-iii-aranote-trial-in-men-with-metastatic-hormone-sensitive-prostate-cancer/)

July 11, 2024


Not intended for UK Media


AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease


[READ MORE](https://www.bayer.com/media/en-us/askbio-receives-fda-fast-track-and-mhra-innovation-passport-designations-for-ab-1005-investigational-gdnf-gene-therapy-for-parkinsons-disease/)

June 21, 2024


Not intended for U.S. and UK Media - Joint press release of Charité and Bayer


Berlin Center for Gene and Cell Therapies kicked off in Berlin


[READ MORE](https://www.bayer.com/media/en-us/berlin-center-for-gene-and-cell-therapies-kicked-off-in-berlin/)

June 17, 2024


Crop Science Innovation Update 2024:


Bayer to deliver ten blockbusters in ten years


[READ MORE](https://www.bayer.com/media/en-us/bayer-to-deliver-ten-blockbusters-in-ten-years/)

May 28, 2024


World Seed Congress 2024:


Bayer advances genome-editing initiatives for nutrition enhanced vegetables


[READ MORE](https://www.bayer.com/media/en-us/bayer-advances-genome-editing-initiatives-for-nutrition-enhanced-vegetables/)

May 16, 2024


Not intended for UK Media – Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting:


Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause


[READ MORE](https://www.bayer.com/media/en-us/elinzanetant-significantly-reduces-frequency-and-severity-of-moderate-to-severe-hot-flashes-associated-with-menopause/)

May 14, 2024


Bayer Group:


First-quarter performance as expected


[READ MORE](https://www.bayer.com/media/en-us/first-quarter-performance-as-expected/)

April 26, 2024


CEO Bill Anderson at the Annual Stockholders’ Meeting:


“Restore trust and get Bayer on track for better performance”


[READ MORE](https://www.bayer.com/media/en-us/restore-trust-and-get-bayer-on-track-for-better-performance/)

April 23, 2024


Bayer Aims to Launch First Bioinsecticide for Arable Crops


[READ MORE](https://www.bayer.com/media/en-us/bayer-aims-to-launch-first-bioinsecticide-for-arable-crops/)

March 20, 2024


Not intended for UK Media


Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth


[READ MORE](https://www.bayer.com/media/en-us/bayer-pharmaceuticals-streamlines-leadership-team-for-next-phase-of-growth/)

March 19, 2024


Not intended for UK Media


Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant


[READ MORE](https://www.bayer.com/media/en-us/positive-topline-results-from-phase-iii-long-term-study-oasis-3-support-submissions-for-marketing-authorization-for-bayers-elinzanetant/)

March 05, 2024


Financial News Conference:


Bayer aims to enhance performance and regain strategic flexibility by 2026 – adjusted guidance for 2023 achieved


[READ MORE](https://www.bayer.com/media/en-us/bayer-aims-to-enhance-performance-and-regain-strategic-flexibility-by-2026--adjusted-guidance-for-2023-achieved/)

February 29, 2024


Heiko Schipper to leave the company on April 30, 2024


Julio Triana appointed to Board of Management of Bayer AG and President of the Consumer Health Division


[READ MORE](https://www.bayer.com/media/en-us/julio-triana-appointed-to-board-of-management-of-bayer-ag--and-president-of-the-consumer-health-division/)

February 29, 2024


Elections at the Annual Stockholders' Meeting on April 26, 2024:


Bayer aims to further extend expertise in Supervisory Board


[READ MORE](https://www.bayer.com/media/en-us/bayer-aims-to-further-extend-expertise-in-supervisory-board/)

February 26, 2024


Not intended for UK Media


Bayer receives U.S. FDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations


[READ MORE](https://www.bayer.com/media/en-us/bayer-receives-us-fda-breakthrough-therapy-designation-for-bay-2927088-for-non-small-cell-lung-cancer-harboring-her2-activating-mutations/)

February 19, 2024


Bayer plans to amend its dividend policy to reduce debt


[READ MORE](https://www.bayer.com/media/en-us/bayer-plans-to-amend-its-dividend-policy-to-reduce-debt/)

January 24, 2024


Not intended for U.S. and UK Media


Application for regulatory approval of Aflibercept 8 mg accepted in China


[READ MORE](https://www.bayer.com/media/en-us/application-for-regulatory-approval-of-aflibercept-8-mg-accepted-in-china/)

January 18, 2024


Not intended for U.S. and UK Media


New Eylea™ 8 mg approved in Japan


[READ MORE](https://www.bayer.com/media/en-us/new-eylea-8-mg-approved-in-japan/)

January 17, 2024


Board of Management and employee representatives agree on future direction


Bayer aims to sustainably improve performance with new organization


[READ MORE](https://www.bayer.com/media/en-us/bayer-aims-to-sustainably-improve-performance-with-new-organization/)

January 08, 2024


Not intended for U.S. and UK Media


New Eylea™ 8 mg approved in EU


[READ MORE](https://www.bayer.com/media/en-us/new-eylea-8-mg-approved-in-eu/)

January 08, 2024


Not intended for UK Media


Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies


[READ MORE](https://www.bayer.com/media/en-us/bayers-elinzanetant-meets-all-primary-and-key-secondary-endpoints-in-pivotal-oasis-1-and-2-phase-iii-studies/)

January 04, 2024


Not intended for UK Media


AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary endpoint


[READ MORE](https://www.bayer.com/media/en-us/askbio-phase-ib-trial-of-ab-1005-gene-therapy-in-patients-with-parkinsons-disease-meets-primary-endpoint/)

November 19, 2023


Not intended for U.S. and UK Media


OCEANIC-AF study stopped early due to lack of efficacy


[READ MORE](https://www.bayer.com/media/en-us/oceanic-af-study-stopped-early-due-to-lack-of-efficacy/)

November 08, 2023


Bayer Group:


Third quarter below prior year as expected – Group outlook confirmed


[READ MORE](https://www.bayer.com/media/en-us/third-quarter-below-prior-year-as-expected---group-outlook-confirmed/)

October 16, 2023


6th International Rice Congress in Manila, Philippines:


Bayer introduces agricultural system for direct-seeded rice with potential to reduce greenhouse gas emissions and water use by up to 40 percent


[READ MORE](https://www.bayer.com/media/en-us/bayer-introduces-agricultural-system-for-direct-seeded-rice-with-potential-to-reduce-greenhouse-gas-emissions-and-water-use-by-up-to-40-percent/)

October 05, 2023


Not intended for UK Media


Bayer to partner with Twist Bioscience to accelerate drug discovery


[READ MORE](https://www.bayer.com/media/en-us/bayer-to-partner-with-twist-bioscience-to-accelerate-drug-discovery/)

September 21, 2023


More than 70% of farmers have already seen large impacts of climate change on their farm, new global research across 8 countries reveals


[READ MORE](https://www.bayer.com/media/en-us/more-than-70-of-farmers-have-already-seen-large-impacts-of-climate-change-on-their-farm-new-global-research-across-8-countries-reveals/)

September 18, 2023


Not intended for UK Media


Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator


[READ MORE](https://www.bayer.com/media/en-us/vividion-therapeutics-starts-phase-i-clinical-trial-in-advanced-solid-tumors-with-keap1-activator/)

August 29, 2023


Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn


[READ MORE](https://www.bayer.com/media/en-us/gene-editing-pairwise-and-bayer-start-new-five-year-multi-million-dollar-collaboration-to-further-advance-short-stature-corn/)

August 28, 2023


Not intended for UK Media


BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint


[READ MORE](https://www.bayer.com/media/en-us/bluerocks-phase-i-study-with-bemdaneprocel-in-patients-with-parkinsons-disease-meets-primary-endpoint/)

August 21, 2023


Heike Prinz appointed to Board of Management of Bayer AG


[READ MORE](https://www.bayer.com/media/en-us/heike-prinz-appointed-to-board-of-management-of-bayer-ag/)

August 10, 2023


Not intended for U.S. and UK Media – Two-year topline results from the pivotal study PULSAR:


Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years


[READ MORE](https://www.bayer.com/media/en-us/aflibercept-8-mg-first-to-achieve-sustained-vision-gains-with-more-than-70-of-patients-extended-to-intervals-between-16-and-24-weeks-in-wet-age-related-macular-degeneration-at-two-years/)

August 08, 2023


Bayer Group:


Second quarter impacted by declines in glyphosate business


[READ MORE](https://www.bayer.com/media/en-us/second-quarter-impacted-by-declines-in-glyphosate-business/)

July 24, 2023


Bayer lowers full-year outlook


[READ MORE](https://www.bayer.com/media/en-us/bayer-lowers-full-year-outlook/)

June 29, 2023


Not intended for U.S. and UK Media


Aflibercept 8 mg in diabetic macular edema first to achieve sustained vision gains with up to 83% of patients extended to 16-24 weeks at two years


[READ MORE](https://www.bayer.com/media/en-us/aflibercept-8-mg-in-diabetic-macular-edema-first-to-achieve-sustained-vision-gains-with-up-to-83-of-patients-extended-to--16-24-weeks-at-two-years/)

June 22, 2023


Not intended for U.S. and UK Media


Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes


[READ MORE](https://www.bayer.com/media/en-us/bayer-to-start-phase-iii-study-with-finerenone-in-adults-with-chronic-kidney-disease-and-type-1-diabetes/)

June 20, 2023


Crop Science Innovation Summit 2023:


Bayer sees more than doubling of accessible markets and potential to shape regenerative agriculture on more than 400 million acres


[READ MORE](https://www.bayer.com/media/en-us/bayer-sees-more-than-doubling-of-accessible-markets-and-potential-to-shape-regenerative-agriculture-on-more-than-400-million-acres/)

May 23, 2023


NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN


Bayer issues new senior bonds with a volume of 3 billion euros


[READ MORE](https://www.bayer.com/media/en-us/bayer-issues-new-senior-bonds-with-a-volume-of-3-billion-euros/)

May 16, 2023


Not intended for UK Media


Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program


[READ MORE](https://www.bayer.com/media/en-us/bayer-receives-us-fda-fast-track-designation-for-asundexian-atrial-fibrillation-program/)

May 11, 2023


Bayer Group business performance in the first quarter of 2023:


Slow start to the year as expected


[READ MORE](https://www.bayer.com/media/en-us/slow-start-to-the-year-as-expected/)

May 10, 2023


Not intended for U.S. and UK Media


Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion


[READ MORE](https://www.bayer.com/media/en-us/bayer-initiates-phase-iii-study-to-investigate-aflibercept-8-mg-in-retinal-vein-occlusion/)

April 28, 2023


CEO Werner Baumann at the Annual Stockholders’ Meeting:


“Bayer has excellent prospects for the future”


[READ MORE](https://www.bayer.com/media/en-us/bayer-has-excellent-prospects-for-the-future/)

April 05, 2023


Bayer to invest a total of 60 million euros in its Ukrainian seed production site


[READ MORE](https://www.bayer.com/media/en-us/bayer-to-invest-a-total-of-60-million-euros-in-its-ukrainian-seed-production-site/)

April 03, 2023


Internationally renowned experts form independent Bayer Bioethics Council


Bayer establishes Bioethics Council


[READ MORE](https://www.bayer.com/media/en-us/bayer-establishes-bioethics-council/)

[NEWS OVERVIEW](https://www.bayer.com/media/en-us/)

[![30-teaser](/sites/default/files/styles/16_9_aspect_ratio/public/2022-04/30-teaser_0.jpg?h=c673cd1c&itok=bUqiEQzQ)\
\
Engagement\
\
**30 Years From Now** READ MORE](/en/pharma/30-years-now "")

![A person in blue gloves is holding a test tube.](/sites/default/files/styles/16_9_small/public/2021-09/development_1.jpg?h=b3719b08&itok=-_hikJ29)

Innovation

**Development Pipeline**

[![An abstract image of yellow coronaviruses on a blue background.](/sites/default/files/styles/16_9_small/public/2021-09/EE6A5E65-2726-4385-9410-49866DAB2C26.jpeg?h=4f66e6c8&itok=dL4Bhi29)\
\
Update on Covid-19\
\
**Our Commitment During the Coronavirus Pandemic**\
\
READ MORE](/en/covid-19/coronavirus-covid-19-contact)

- [twitter](#twitter)

[BayerPharma](http://www.twitter.com/BayerPharma)

Monday, February 13, 2023

<a href='https://twitter.com/hashtag/NEWS?src=hashtag\_click'>#NEWS</a>: We are excited to announce that we have completed the acquisition of the global strategic imaging AI platfor… https://t.co/oKhjRjYeBi

[READ MORE](https://twitter.com/BayerPharma/status/1625035799887577088)

![The skyline of a city at dusk with the tv tower in the background.](/sites/default/files/styles/16_9_small/public/2021-09/Strengthening_ip_1%281%29_1.jpg?h=4f66e6c8&itok=rIjlbz3Y)

#WeWontRest

**For a brighter tomorrow \#WeWontRest**

[![Clinical Trials](/sites/default/files/styles/16_9_small/public/2022-04/CTE-3_1.png?h=c68e8d4f&itok=Zp4TQbrU)\
\
**Bayer Clinical Trials**\
\
READ MORE](https://clinicaltrials.bayer.com/)

Explore Your Topic

[![Two women hugging each other in front of a mirror.](/sites/default/files/styles/16_9_small/public/2021-09/Section-Heros-Cancer_1.jpg?h=4f66e6c8&itok=RxT7rJMN)\
\
**Cancer**\
\
READ MORE](/en/pharma/oncology)

![A group of people looking at a microscope.](/sites/default/files/styles/16_9_small/public/2021-09/Section-Heros-tech_1.jpg?h=4f66e6c8&itok=yL99lpkM)

**Innovation and Research**

[![A man in a white shirt is holding a picture of a child.](/sites/default/files/styles/16_9_small/public/2021-09/Section-Heros-who_1.jpg?h=4f66e6c8&itok=zScEOMgn)\
\
**Sustainable Healthcare**\
\
READ MORE](/en/pharma/initiatives)

![A person is reaching for a book in a library.](/sites/default/files/styles/16_9_small/public/2021-09/Section-Heros-rack.jpg?h=ad915ef3&itok=0aPqBOfP)

**Our Engagement**

![Pipeline Insights Stories](/sites/default/files/styles/16_9_aspect_ratio/public/2022-04/Bildschirmfoto%202019-11-28%20um%2016.38.25.jpg?h=c673cd1c&itok=8fGt_GQv)

Innovation

# Pipeline Insights Stories

Global Health Policy Blog

[![An elderly woman is using a tablet to check her blood pressure.](/sites/default/files/styles/16_9_small/public/2021-09/Health_data_on_a_smartphone_2.jpg?h=b3719b08&itok=s7paXMHZ)\
\
HEALTH POLICY INSIGHTS\
\
**The Promise of Digital Health**\
\
READ MORE](/en/pharma/promise-digital-health)

[![A nurse is putting a stethoscope on an elderly patient.](/sites/default/files/styles/16_9_small/public/2021-08/Nurse_listening_to_patients_heartbeat.jpg?h=b3719b08&itok=UcpyBAHE)\
\
HEALTH POLICY INSIGHTS\
\
**The Economic And Societal Impact of Cardiovascular Disease**\
\
READ MORE](/en/pharma/economic-and-societal-impact-cardiovascular-disease)

[![A male doctor talking to a female patient.](/sites/default/files/styles/16_9_small/public/2021-08/Doctor_advising_patient_1_0.jpg?h=b3719b08&itok=9GAiRM3k)\
\
HEALTH POLICY INSIGHTS\
\
**The Expert Patient**\
\
READ MORE](/en/pharma/expert-patient)

[VISIT BLOG](/en/pharma/news-stories)

Last Updated: Thursday, December 21, 2023

- Our Business  - [Pharmaceuticals](https://pharma.bayer.com/)
  - [Consumer Health](/en/consumer-health/consumer-health-division-bayer)
  - [Crop Science](https://www.cropscience.bayer.com/)
  - [Our Products](/en/products/products-from-A-to-Z)
  - [Bayer Worldwide](/en/worldwide/bayer-worldwide)
- Magazines & Reports  - [News & Stories](/en/news-stories)
- Stay Tuned  - [Job Postings](https://talent.bayer.com/careers?hl=en)
  - [Latest News](https://www.bayer.com/media/en-us/)
  - [Newsletter](https://www.bayer.com/media/en-us/newsletter-subscription/)
  - [Bayer Share Price](/en/investors/shareholder-information)

Get in Touch

Do you have any queries or comments?

[Global Form](/en/contact-us)

[Report a side effect](/en/health/report-side-effect)

Follow Us


[Facebook](http://www.facebook.com/Bayer)

[Twitter](http://twitter.com/bayer)

[YouTube](http://www.youtube.com/user/BayerTVinternational)

[LinkedIn](http://www.linkedin.com/company/bayer)

[Instagram](http://instagram.com/bayerofficial)

[RSS Feed](/rss)

Copyright © Bayer AG

- [Conditions of Use](/en/conditions-of-use)
- [Privacy Statement](/en/privacy-statement)
- Cookie Settings
- [Imprint](/en/imprint)

[Sitemap](/en/sitemap)

Top